Obesity
Showing NaN - NaN of 116
Obesity, Overweight and Obesity Trial in United States (LY3305677, Placebo)
Not yet recruiting
- Obesity
- Overweight and Obesity
- LY3305677
- Placebo
-
Mesa, Arizona
- +23 more
Nov 6, 2023
Obesity, Healthy Volunteers Trial in Dallas (S309309, Itraconazole)
Recruiting
- Obesity
- Healthy Volunteers
-
Dallas, TexasFortrea Clinical Research Unit Inc.
Oct 30, 2023
Spinal Cord Injuries, Obesity, Cardiometabolic Syndrome Trial in United States (PVA Consumer Guide, WebMD)
Not yet recruiting
- Spinal Cord Injuries
- +2 more
- PVA Consumer Guide
- WebMD
-
Washington, District of Columbia
- +4 more
Aug 16, 2023
Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Retatrutide
- Placebo
-
Los Angeles, California
- +91 more
Jul 10, 2023
Obesity Trial in Dallas (PHP, SMA)
Completed
- Obesity
- PHP
- SMA
-
Dallas, TexasMethodist Charlton Family Medicine
Jul 6, 2023
Obesity, Overweight Trial in Puerto Rico, United States (Tirzepatide, Semaglutide 2.4 mg)
Recruiting
- Obesity
- Overweight
- Tirzepatide
- Semaglutide 2.4 mg
-
Birmingham, Alabama
- +31 more
Apr 26, 2023
Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)
Recruiting
- Type 2 Diabetes
- +5 more
- Orforglipron
- Insulin Glargine
-
Muscle Shoals, Alabama
- +320 more
Apr 12, 2023
Obesity Trial in United States (Semaglutide 2.4 mg and NNC0165-1875 2.0 mg, Semaglutide 2.4 mg and 2.0 mg, Semaglutide 2.4 mg
Completed
- Obesity
- Semaglutide 2.4 mg and NNC0165-1875 2.0 mg
- +3 more
-
Walnut Creek, California
- +13 more
Jan 23, 2023
Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Overweight
- +2 more
- Cagrilintide
- +3 more
-
Concord, California
- +147 more
Jan 24, 2023
Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)
Recruiting
- Obesity
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo
-
Birmingham, Alabama
- +73 more
Jan 24, 2023
Overweight, Obesity Trial (Semaglutide, Placebo semaglutide)
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo semaglutide
-
Birmingham, Alabama
- +21 more
Jan 24, 2023
Obesity, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Obesity
- Heart Failure With Preserved Ejection Fraction
- Tirzepatide
- Placebo
-
Huntsville, Alabama
- +144 more
Jan 18, 2023
Obesity and OSA in Pregnancy
Recruiting
- Obesity
- +3 more
-
Dallas, Texas
- +1 more
Jan 9, 2023